Cancer Biopsy Market Size, Share & Trends Analysis Report By Product (Kits & Consumables, Instruments, Services), By Type (Tissue Biopsies, Liquid Biopsies), By Application, And Segment Forecasts, 2021 - 2027
This report can be delivered to the clients within 72 Business Hours
Cancer Biopsy Market Growth & Trends
The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 11.13% from 2021 to 2027. The expanding landscape of molecular medicine paved the way for the development of new devices for the molecular characterization of cancers. Thus, increasing adoption and product approvals for liquid biopsies are expected to drive the overall market.
The kits and consumables product segment is expected to maintain its lead in the years to come. Acknowledging this trend, various market players have invested in the development of novel kits in order to expand their biopsy kits portfolio. For instance, in April 2021, Sysmex Europe GmbH, along with Sysmex Inostics GmbH, introduced Plasma-SeqSensei liquid biopsy research use only (RUO) kits in EMEA.
The tissue biopsies segment emerged as the dominant type segment in 2020. Shortcomings of liquid biopsies such as the lack of robust efficacy evaluations and associated high costs are currently bridged by tissue biopsies. This has made tissue biopsy a gold-standard procedure in the present diagnostic scenario.
Liquid biopsies are expected to offer lucrative opportunities in the field of oncology-based personalized medicine and genomic data analysis. Recognizing the potential of these tests, the regulatory bodies are actively supporting the commercialization of these products and increasing the use of these assays in clinics. For instance, in November 2020, the FoundationOne Liquid CDx test was approved by the U.S. FDA as a companion diagnostic device for multiple cancers.
The liquid biopsies segment is expected to expand at an exponential rate in the coming years, wherein increasing investments and strategic initiatives by companies involved in biopharmaceutical manufacturing and genomic data analysis are expected to play a central role. The emerging companies are inclined towards collaborating with well-established industry participants, including SOPHiA Genetics, QIAGEN Bioinformatics, Agilent Technologies, and Fabric Genomics. This trend is further expected to favor the overall market growth.
Key players are focusing on developing novel biopsy platforms, set to achieve business expansion, further contributing to the revenue generation in the market. In March 2021, Quick-Core Auto Biopsy System for biopsy procedure soft tissue biopsy was launched by IZI Medical Products. This product is fully automated, which is built based on the company’s proprietary semi-automatic system, Quick-Core.
Cancer Biopsy Market Report Highlights
Cancer Biopsy Market Growth & Trends
The global cancer biopsy market size is expected to reach USD 44.51 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 11.13% from 2021 to 2027. The expanding landscape of molecular medicine paved the way for the development of new devices for the molecular characterization of cancers. Thus, increasing adoption and product approvals for liquid biopsies are expected to drive the overall market.
The kits and consumables product segment is expected to maintain its lead in the years to come. Acknowledging this trend, various market players have invested in the development of novel kits in order to expand their biopsy kits portfolio. For instance, in April 2021, Sysmex Europe GmbH, along with Sysmex Inostics GmbH, introduced Plasma-SeqSensei liquid biopsy research use only (RUO) kits in EMEA.
The tissue biopsies segment emerged as the dominant type segment in 2020. Shortcomings of liquid biopsies such as the lack of robust efficacy evaluations and associated high costs are currently bridged by tissue biopsies. This has made tissue biopsy a gold-standard procedure in the present diagnostic scenario.
Liquid biopsies are expected to offer lucrative opportunities in the field of oncology-based personalized medicine and genomic data analysis. Recognizing the potential of these tests, the regulatory bodies are actively supporting the commercialization of these products and increasing the use of these assays in clinics. For instance, in November 2020, the FoundationOne Liquid CDx test was approved by the U.S. FDA as a companion diagnostic device for multiple cancers.
The liquid biopsies segment is expected to expand at an exponential rate in the coming years, wherein increasing investments and strategic initiatives by companies involved in biopharmaceutical manufacturing and genomic data analysis are expected to play a central role. The emerging companies are inclined towards collaborating with well-established industry participants, including SOPHiA Genetics, QIAGEN Bioinformatics, Agilent Technologies, and Fabric Genomics. This trend is further expected to favor the overall market growth.
Key players are focusing on developing novel biopsy platforms, set to achieve business expansion, further contributing to the revenue generation in the market. In March 2021, Quick-Core Auto Biopsy System for biopsy procedure soft tissue biopsy was launched by IZI Medical Products. This product is fully automated, which is built based on the company’s proprietary semi-automatic system, Quick-Core.
Cancer Biopsy Market Report Highlights
- By product, kits and consumables accounted for the largest revenue share in 2020 and are anticipated to maintain its lead throughout the forecast period. The adoption of kits and consumables is expected to increase owing to the significant transition from tumor to liquid biopsy
- Based on type, tissue biopsies are still considered to be a mainstay of biopsies and are largely adopted across various diagnosis applications. Additionally, tumor biopsy is most adopted for diagnosis on individual levels, along with monitoring the effects of an ongoing oncology treatment
- North America held the largest revenue share in 2020 owing to the concentrated pool of active organizations and cancer foundations. The strong network of government organizations and private cancer foundations in the U.S. has made significant contributions to the regional revenue generation capacity
- In terms of application, breast cancer dominated the global market in 2020 and is expected to maintain its lead throughout the forecast period. Open surgical biopsy is considered to be a reference standard for the evaluation of patients with a suspicious breast lesion. This is attributed to its proven accuracy in diagnosing breast lesions, further contributing to the revenue generated by this segment
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.5.1.1 End-use landscape assessment
1.5.2 Market origin assessment
1.5.3 Oncology diagnosis: Market competition analysis
1.6 Market Formulation and Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.2 Approach 1: Commodity Flow Approach
1.7.3 Approach 2: Country-wise market estimation using bottom-up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary, 2020
CHAPTER 4 MARKET VARIABLES, TRENDS, AND SCOPE
4.1 Market Segmentation
4.2 Cancer Biopsy Market Lineage Outlook
4.2.1 Parent market outlook
4.2.2 TOP 10 liquid biopsy innovators
4.3 Penetration and Growth Prospect Mapping, by Product, 2020
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Market Driver Analysis
5.1.1 Advent of liquid biopsy
5.1.2 Transition of novel oncology diagnostics from bench to clinics
5.1.3 Advancements in quality and payment pertaining to genetic cancer tests
5.2 Market Restraint Analysis
5.2.1 Risks associated with biopsy procedures
5.2.2 Technical and clinical challenges
CHAPTER 6 BUSINESS ENVIRONMENT ANALYSIS
6.1 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
6.1.1 Political landscape
6.1.1.1 Strengths
6.1.1.2 Weaknesses
6.1.1.3 Opportunities
6.1.1.4 Threats
6.1.2 Economic landscape
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.1.3 Social landscape
6.1.3.1 Strengths
6.1.3.2 Weaknesses
6.1.3.3 Opportunities
6.1.3.4 Threats
6.1.4 Technology landscape
6.1.4.1 Strengths
6.1.4.2 Weaknesses
6.1.4.3 Opportunities
6.1.4.4 Threats
6.2 Porter’s Five Forces Analysis
6.3 Market Entry Strategies
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Market Impact Analysis by Key Participants
7.1.1 Ansoff matrix
7.1.2 Company/Competition Categorization (Primary & Secondary market participants)
CHAPTER 8 CANCER BIOPSY MARKET: PRODUCT BUSINESS ANALYSIS
8.1 Cancer Biopsy Market: Product Movement Analysis
8.2 Instruments
8.2.1 Cancer Biopsy instruments market estimates and forecasts, 2018 - 2027 (USD Million)
8.3 Kits and Consumables
8.3.1 Cancer Biopsy kits and consumables market estimates and forecast, 2018 - 2027 (USD Million)
8.4 Services
8.4.1 Cancer biopsy services market estimates and forecast, 2018 - 2027 (USD Million)
CHAPTER 9 CANCER BIOPSY MARKET: TYPE BUSINESS ANALYSIS
9.1 Cancer Biopsy Market: Type Movement Analysis
9.2 Cancer Biopsy Market: Comparative Analysis of Type
9.3 Tissue Biopsies
9.3.1 Cancer Tissue Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.2 Cancer Needle Biopsy
9.3.2.1 Cancer needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.3 Cancer fine needle aspiration (FNA) biopsy
9.3.3.1 Cancer fine needle aspiration (FNA) biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.4 Cancer core needle biopsy (CNB)
9.3.4.1 Cancer core needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.5 Cancer surgical biopsy
9.3.5.1 Cancer surgical biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.4 Liquid Biopsies
9.4.1 Cancer liquid Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.5 Others
9.5.1 Cancer other Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
CHAPTER 10 CANCER BIOPSY MARKET: APPLICATION BUSINESS ANALYSIS
10.1 Cancer Biopsy Market: Application Movement Analysis
10.2 Breast Cancer
10.2.1 Breast cancer biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
10.3 Colorectal Cancer
10.3.1 Colorectal cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.4 Cervical Cancer
10.4.1 Cervical cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.5 Lung Cancer
10.5.1 Lung cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.6 Prostate Cancer
10.6.1 Prostate cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.7 Skin Cancer
10.7.1 Skin cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.8 Blood Cancer
10.8.1 Blood cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.9 Kidney Cancer
10.9.1 Kidney cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.10 Liver Cancer
10.10.1 Liver cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.11 Pancreatic Cancer
10.11.1 Pancreatic cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.12 Ovarian Cancer
10.12.1 Ovarian cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.13 Others
10.13.1 Other cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
CHAPTER 11 CANCER BIOPSY MARKET: REGIONAL BUSINESS ANALYSIS
11.1 Cancer Biopsy Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.2.2.2 U.S. Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.2.2.3 U.S. Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.2.3 Canada
11.2.3.1 Canada Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.2.3.2 Canada Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.2.3.3 Canada Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3 Europe
11.3.1 Europe Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.3.2 Germany
11.3.2.1 Germany Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.2.2 Germany Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.2.3 Germany Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.3 U.K.
11.3.3.1 U.K. Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.3.2 U.K. Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.3.3 U.K. Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.4 France
11.3.4.1 France Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.4.2 France Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.4.3 France Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.5 Spain
11.3.5.1 Spain Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.5.2 Spain Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.5.3 Spain Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.6 Italy
11.3.6.1 Italy Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.6.2 Italy Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.6.3 Italy Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4 Asia-Pacific
11.4.1 Asia Pacific Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.4.2 Japan
11.4.2.1 Japan Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.2.2 Japan Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.2.3 Japan Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.3 China
11.4.3.1 China Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.3.2 China Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.3.3 China Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.4 India
11.4.4.1 India Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.4.2 India Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.4.3 India Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.5 Thailand
11.4.5.1 Thailand Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.5.2 Thailand Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.5.3 Thailand Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.6 South Korea
11.4.6.1 South Korea Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.6.2 South Korea Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.6.3 South Korea Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5 Latin America
11.5.1 Latin America Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.2.2 Brazil Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.2.3 Brazil Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5.3 Mexico
11.5.3.1 Mexico Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.3.2 Mexico Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.3.3 Mexico Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5.4 Argentina
11.5.4.1 Argentina Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.4.2 Argentina Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.4.3 Argentina Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.6 Middle East and Africa
11.6.1 MEA Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD
Million)
11.6.2 South Africa
11.6.2.1 South Africa Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.6.2.2 South Africa Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.6.2.3 South Africa Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.6.3.2 Saudi Arabia Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.6.3.3 Saudi Arabia Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1 QIAGEN
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Strategic initiatives
12.1.2 Illumina, Inc.
12.1.2.1 Company overview
12.1.2.2 Product benchmarking
12.1.2.3 Financial performance
12.1.2.4 Strategic initiatives
12.1.3 ANGLE plc
12.1.3.1 Company overview
12.1.3.2 Financial performance
12.1.3.3 Product benchmarking
12.1.3.4 Strategic initiatives
12.1.4 BD (Becton, Dickinson and Company)
12.1.4.1 Company overview
12.1.4.2 Financial performance
12.1.4.3 Product benchmarking
12.1.4.4 Strategic initiatives
12.1.5 Myriad Genetics
12.1.5.1 Company overview
12.1.5.2 Counsyl, Inc.
12.1.5.2.1 Company overview
12.1.5.3 Financial performance
12.1.5.4 Product benchmarking
12.1.5.5 Strategic initiatives
12.1.6 Hologic, Inc.
12.1.6.1 Company overview
12.1.6.2 Financial performance
12.1.6.3 Product benchmarking
12.1.7 BIOCEPT, INC.
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic initiatives
12.1.8 Thermo Fisher Scientific, Inc.
12.1.8.1 Company overview
12.1.8.2 Financial performance
12.1.8.3 Product benchmarking
12.1.9 Danaher
12.1.9.1 Company overview
12.1.9.2 Beckman Coulter, Inc.
12.1.9.3 Radiometer Medical ApS
12.1.9.4 HemoCue AB
12.1.9.5 Financial performance
12.1.9.6 Product benchmarking
12.1.10 F. Hoffmann-La Roche Ltd.
12.1.10.1 Company overview
12.1.10.2 FOUNDATION MEDICINE, INC.
12.1.10.3 Financial performance
12.1.10.4 Product benchmarking
12.1.11 Lucence Diagnostics Pte. Ltd.
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.11.4 Strategic initiatives
12.1.12 GRAIL, Inc.
12.1.12.1 Company overview
12.1.12.2 Financial performance
12.1.12.3 Product benchmarking
12.1.12.4 Strategic initiatives
12.1.13 Guardant Health
12.1.13.1 Company overview
12.1.13.2 Financial performance
12.1.13.3 Product benchmarking
12.1.13.4 Strategic initiatives
12.1.14 Exact Sciences Corporation
12.1.14.1 Company overview
12.1.14.2 Financial performance
12.1.14.3 Product benchmarking
12.1.14.4 Strategic initiatives
12.1.15 Freenome Holdings, Inc.
12.1.15.1 Company overview
12.1.15.2 Financial performance
12.1.15.3 Product benchmarking
12.1.15.4 Strategic initiatives
12.1.16 Biodesix (Integrated Diagnostics)
12.1.16.1 Company overview
12.1.16.2 Financial performance
12.1.16.3 Product benchmarking
12.1.16.4 Strategic initiatives
12.1.17 Oncimmune
12.1.17.1 Company overview
12.1.17.2 Financial performance
12.1.17.3 Product benchmarking
12.1.17.4 Strategic initiatives
12.1.18 Epigenomics AG
12.1.18.1 Company overview
12.1.18.2 Financial performance
12.1.18.3 Product benchmarking
12.1.18.4 Strategic initiatives
12.1.19 HelioHealth (Laboratory for Advanced Medicine)
12.1.19.1 Company overview
12.1.19.2 Financial performance
12.1.19.3 Product benchmarking
12.1.19.4 Strategic initiatives
12.1.20 Genesystems, Inc. (Genesys Biolabs)
12.1.20.1 Company overview
12.1.20.2 Financial performance
12.1.20.3 Product benchmarking
12.1.20.4 Strategic initiatives
12.1.21 Chronix Biomedical, Inc.
12.1.21.1 Company overview
12.1.21.2 Financial performance
12.1.21.3 Product benchmarking
12.1.21.4 Strategic initiatives
12.1.22 Personal Genome Diagnostics Inc.
12.1.22.1 Company overview
12.1.22.2 Financial performance
12.1.22.3 Product benchmarking
12.1.22.4 Strategic initiatives
12.1.23 Natera, Inc.
12.1.23.1 Company overview
12.1.23.2 Financial performance
12.1.23.3 Product benchmarking
12.1.23.4 Strategic initiatives
12.1.24 Personalis Inc.
12.1.24.1 Company overview
12.1.24.2 Financial performance
12.1.24.3 Product benchmarking
12.1.24.4 Strategic initiatives
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 GVR’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details of Primary Research
1.5 Information or Data Analysis
1.5.1 Data Analysis Models
1.5.1.1 End-use landscape assessment
1.5.2 Market origin assessment
1.5.3 Oncology diagnosis: Market competition analysis
1.6 Market Formulation and Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.2 Approach 1: Commodity Flow Approach
1.7.3 Approach 2: Country-wise market estimation using bottom-up approach
1.8 Global Market: CAGR Calculation
1.9 List of Secondary Sources
1.10 List of Primary Sources
CHAPTER 2 MARKET DEFINITIONS
CHAPTER 3 EXECUTIVE SUMMARY
3.1 Market Summary, 2020
CHAPTER 4 MARKET VARIABLES, TRENDS, AND SCOPE
4.1 Market Segmentation
4.2 Cancer Biopsy Market Lineage Outlook
4.2.1 Parent market outlook
4.2.2 TOP 10 liquid biopsy innovators
4.3 Penetration and Growth Prospect Mapping, by Product, 2020
CHAPTER 5 INDUSTRY OUTLOOK
5.1 Market Driver Analysis
5.1.1 Advent of liquid biopsy
5.1.2 Transition of novel oncology diagnostics from bench to clinics
5.1.3 Advancements in quality and payment pertaining to genetic cancer tests
5.2 Market Restraint Analysis
5.2.1 Risks associated with biopsy procedures
5.2.2 Technical and clinical challenges
CHAPTER 6 BUSINESS ENVIRONMENT ANALYSIS
6.1 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
6.1.1 Political landscape
6.1.1.1 Strengths
6.1.1.2 Weaknesses
6.1.1.3 Opportunities
6.1.1.4 Threats
6.1.2 Economic landscape
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.1.3 Social landscape
6.1.3.1 Strengths
6.1.3.2 Weaknesses
6.1.3.3 Opportunities
6.1.3.4 Threats
6.1.4 Technology landscape
6.1.4.1 Strengths
6.1.4.2 Weaknesses
6.1.4.3 Opportunities
6.1.4.4 Threats
6.2 Porter’s Five Forces Analysis
6.3 Market Entry Strategies
CHAPTER 7 COMPETITIVE ANALYSIS
7.1 Market Impact Analysis by Key Participants
7.1.1 Ansoff matrix
7.1.2 Company/Competition Categorization (Primary & Secondary market participants)
CHAPTER 8 CANCER BIOPSY MARKET: PRODUCT BUSINESS ANALYSIS
8.1 Cancer Biopsy Market: Product Movement Analysis
8.2 Instruments
8.2.1 Cancer Biopsy instruments market estimates and forecasts, 2018 - 2027 (USD Million)
8.3 Kits and Consumables
8.3.1 Cancer Biopsy kits and consumables market estimates and forecast, 2018 - 2027 (USD Million)
8.4 Services
8.4.1 Cancer biopsy services market estimates and forecast, 2018 - 2027 (USD Million)
CHAPTER 9 CANCER BIOPSY MARKET: TYPE BUSINESS ANALYSIS
9.1 Cancer Biopsy Market: Type Movement Analysis
9.2 Cancer Biopsy Market: Comparative Analysis of Type
9.3 Tissue Biopsies
9.3.1 Cancer Tissue Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.2 Cancer Needle Biopsy
9.3.2.1 Cancer needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.3 Cancer fine needle aspiration (FNA) biopsy
9.3.3.1 Cancer fine needle aspiration (FNA) biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.4 Cancer core needle biopsy (CNB)
9.3.4.1 Cancer core needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.3.5 Cancer surgical biopsy
9.3.5.1 Cancer surgical biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.4 Liquid Biopsies
9.4.1 Cancer liquid Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
9.5 Others
9.5.1 Cancer other Biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
CHAPTER 10 CANCER BIOPSY MARKET: APPLICATION BUSINESS ANALYSIS
10.1 Cancer Biopsy Market: Application Movement Analysis
10.2 Breast Cancer
10.2.1 Breast cancer biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
10.3 Colorectal Cancer
10.3.1 Colorectal cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.4 Cervical Cancer
10.4.1 Cervical cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.5 Lung Cancer
10.5.1 Lung cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.6 Prostate Cancer
10.6.1 Prostate cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.7 Skin Cancer
10.7.1 Skin cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.8 Blood Cancer
10.8.1 Blood cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.9 Kidney Cancer
10.9.1 Kidney cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.10 Liver Cancer
10.10.1 Liver cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.11 Pancreatic Cancer
10.11.1 Pancreatic cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.12 Ovarian Cancer
10.12.1 Ovarian cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
10.13 Others
10.13.1 Other cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
CHAPTER 11 CANCER BIOPSY MARKET: REGIONAL BUSINESS ANALYSIS
11.1 Cancer Biopsy Market: Regional Movement Analysis
11.2 North America
11.2.1 North America Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.2.2.2 U.S. Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.2.2.3 U.S. Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.2.3 Canada
11.2.3.1 Canada Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.2.3.2 Canada Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.2.3.3 Canada Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3 Europe
11.3.1 Europe Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.3.2 Germany
11.3.2.1 Germany Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.2.2 Germany Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.2.3 Germany Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.3 U.K.
11.3.3.1 U.K. Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.3.2 U.K. Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.3.3 U.K. Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.4 France
11.3.4.1 France Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.4.2 France Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.4.3 France Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.5 Spain
11.3.5.1 Spain Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.5.2 Spain Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.5.3 Spain Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.3.6 Italy
11.3.6.1 Italy Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.3.6.2 Italy Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.3.6.3 Italy Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4 Asia-Pacific
11.4.1 Asia Pacific Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.4.2 Japan
11.4.2.1 Japan Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.2.2 Japan Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.2.3 Japan Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.3 China
11.4.3.1 China Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.3.2 China Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.3.3 China Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.4 India
11.4.4.1 India Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.4.2 India Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.4.3 India Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.5 Thailand
11.4.5.1 Thailand Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.5.2 Thailand Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.5.3 Thailand Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.4.6 South Korea
11.4.6.1 South Korea Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.4.6.2 South Korea Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.4.6.3 South Korea Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5 Latin America
11.5.1 Latin America Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.2.2 Brazil Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.2.3 Brazil Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5.3 Mexico
11.5.3.1 Mexico Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.3.2 Mexico Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.3.3 Mexico Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.5.4 Argentina
11.5.4.1 Argentina Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.5.4.2 Argentina Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.5.4.3 Argentina Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.6 Middle East and Africa
11.6.1 MEA Cancer Biopsy market estimates and forecast, 2018 - 2027 (USD
Million)
11.6.2 South Africa
11.6.2.1 South Africa Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.6.2.2 South Africa Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.6.2.3 South Africa Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia Cancer Biopsy market estimates and forecast, by product, 2018 - 2027 (USD Million)
11.6.3.2 Saudi Arabia Cancer Biopsy market estimates and forecast, by type, 2018 - 2027 (USD Million)
11.6.3.3 Saudi Arabia Cancer Biopsy market estimates and forecast, by application, 2018 - 2027 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Company Profiles
12.1.1 QIAGEN
12.1.1.1 Company overview
12.1.1.2 Financial performance
12.1.1.3 Product benchmarking
12.1.1.4 Strategic initiatives
12.1.2 Illumina, Inc.
12.1.2.1 Company overview
12.1.2.2 Product benchmarking
12.1.2.3 Financial performance
12.1.2.4 Strategic initiatives
12.1.3 ANGLE plc
12.1.3.1 Company overview
12.1.3.2 Financial performance
12.1.3.3 Product benchmarking
12.1.3.4 Strategic initiatives
12.1.4 BD (Becton, Dickinson and Company)
12.1.4.1 Company overview
12.1.4.2 Financial performance
12.1.4.3 Product benchmarking
12.1.4.4 Strategic initiatives
12.1.5 Myriad Genetics
12.1.5.1 Company overview
12.1.5.2 Counsyl, Inc.
12.1.5.2.1 Company overview
12.1.5.3 Financial performance
12.1.5.4 Product benchmarking
12.1.5.5 Strategic initiatives
12.1.6 Hologic, Inc.
12.1.6.1 Company overview
12.1.6.2 Financial performance
12.1.6.3 Product benchmarking
12.1.7 BIOCEPT, INC.
12.1.7.1 Company overview
12.1.7.2 Financial performance
12.1.7.3 Product benchmarking
12.1.7.4 Strategic initiatives
12.1.8 Thermo Fisher Scientific, Inc.
12.1.8.1 Company overview
12.1.8.2 Financial performance
12.1.8.3 Product benchmarking
12.1.9 Danaher
12.1.9.1 Company overview
12.1.9.2 Beckman Coulter, Inc.
12.1.9.3 Radiometer Medical ApS
12.1.9.4 HemoCue AB
12.1.9.5 Financial performance
12.1.9.6 Product benchmarking
12.1.10 F. Hoffmann-La Roche Ltd.
12.1.10.1 Company overview
12.1.10.2 FOUNDATION MEDICINE, INC.
12.1.10.3 Financial performance
12.1.10.4 Product benchmarking
12.1.11 Lucence Diagnostics Pte. Ltd.
12.1.11.1 Company overview
12.1.11.2 Financial performance
12.1.11.3 Product benchmarking
12.1.11.4 Strategic initiatives
12.1.12 GRAIL, Inc.
12.1.12.1 Company overview
12.1.12.2 Financial performance
12.1.12.3 Product benchmarking
12.1.12.4 Strategic initiatives
12.1.13 Guardant Health
12.1.13.1 Company overview
12.1.13.2 Financial performance
12.1.13.3 Product benchmarking
12.1.13.4 Strategic initiatives
12.1.14 Exact Sciences Corporation
12.1.14.1 Company overview
12.1.14.2 Financial performance
12.1.14.3 Product benchmarking
12.1.14.4 Strategic initiatives
12.1.15 Freenome Holdings, Inc.
12.1.15.1 Company overview
12.1.15.2 Financial performance
12.1.15.3 Product benchmarking
12.1.15.4 Strategic initiatives
12.1.16 Biodesix (Integrated Diagnostics)
12.1.16.1 Company overview
12.1.16.2 Financial performance
12.1.16.3 Product benchmarking
12.1.16.4 Strategic initiatives
12.1.17 Oncimmune
12.1.17.1 Company overview
12.1.17.2 Financial performance
12.1.17.3 Product benchmarking
12.1.17.4 Strategic initiatives
12.1.18 Epigenomics AG
12.1.18.1 Company overview
12.1.18.2 Financial performance
12.1.18.3 Product benchmarking
12.1.18.4 Strategic initiatives
12.1.19 HelioHealth (Laboratory for Advanced Medicine)
12.1.19.1 Company overview
12.1.19.2 Financial performance
12.1.19.3 Product benchmarking
12.1.19.4 Strategic initiatives
12.1.20 Genesystems, Inc. (Genesys Biolabs)
12.1.20.1 Company overview
12.1.20.2 Financial performance
12.1.20.3 Product benchmarking
12.1.20.4 Strategic initiatives
12.1.21 Chronix Biomedical, Inc.
12.1.21.1 Company overview
12.1.21.2 Financial performance
12.1.21.3 Product benchmarking
12.1.21.4 Strategic initiatives
12.1.22 Personal Genome Diagnostics Inc.
12.1.22.1 Company overview
12.1.22.2 Financial performance
12.1.22.3 Product benchmarking
12.1.22.4 Strategic initiatives
12.1.23 Natera, Inc.
12.1.23.1 Company overview
12.1.23.2 Financial performance
12.1.23.3 Product benchmarking
12.1.23.4 Strategic initiatives
12.1.24 Personalis Inc.
12.1.24.1 Company overview
12.1.24.2 Financial performance
12.1.24.3 Product benchmarking
12.1.24.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 Liquid biopsy developing or commercializing companies.
Table 3 Surgical biopsy: Feasibility analysis across cancer diagnosis
Table 4 Comparative analysis of traditional and liquid liver biopsies
Table 5 North America cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 6 North America cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 7 North America cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 8 North America cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 9 North America cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 10 U.S. cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 11 U.S. cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 12 U.S. cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 13 U.S. cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 14 U.S. cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 15 Canada cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 16 Canada cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 17 Canada cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 18 Canada cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 19 Canada cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 20 Europe cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 21 Europe cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 22 Europe cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 23 Europe cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 24 Europe cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 25 Germany cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 26 Germany cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 27 Germany cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 28 Germany cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 29 Germany cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 30 U.K. cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 31 U.K. cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 32 U.K. cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 33 U.K. cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 34 U.K. cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 35 France cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 36 France cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 37 France cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 38 France cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 39 France cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 40 Spain cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 41 Spain cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 42 Spain cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 43 Spain cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 44 Spain cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 45 Italy cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 46 Italy cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 47 Italy cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 48 Italy cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 49 Italy cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 50 Asia Pacific cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 51 Asia Pacific cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 52Asia Pacific cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 53 Asia Pacific cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 54 Asia Pacific cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 55 Japan cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 56 Japan cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 57 Japan cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 58 Japan cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 59 Japan cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 60 China cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 61 China cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 62 China cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 63 China cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 64 China cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 65 India cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 66 India cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 67 India cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 68 India cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 69 India cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 70 South Korea cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 71 South Korea cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 72 South Korea cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 73 South Korea cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 74 South Korea cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 75 Thailand cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 76 Thailand cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 77 Thailand cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 78 Thailand cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 79 Thailand cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 80 Latin America cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 81 Latin America cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 82 Latin America cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 83 Latin America cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 84 Latin America cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 85 Brazil cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 86 Brazil cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 87 Brazil cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 88 Brazil cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 89 Brazil cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 90 Mexico cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 91 Mexico cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 92 Mexico cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 93 Mexico cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 94 Mexico cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 95 Argentina cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 96 Argentina cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 97 Argentina cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 98 Argentina cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 99 Argentina cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 100 MEA cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 101 MEA cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 102 MEA cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 103 MEA cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 104 MEA cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 105 South Africa cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 106 South Africa cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 107 South Africa cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 108 South Africa cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 109 South Africa cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 110 Saudi Arabia cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 111 Saudi Arabia cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 112 Saudi Arabia cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 113 Saudi Arabia cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 114 Saudi Arabia cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 1 List of secondary sources
Table 2 Liquid biopsy developing or commercializing companies.
Table 3 Surgical biopsy: Feasibility analysis across cancer diagnosis
Table 4 Comparative analysis of traditional and liquid liver biopsies
Table 5 North America cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 6 North America cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 7 North America cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 8 North America cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 9 North America cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 10 U.S. cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 11 U.S. cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 12 U.S. cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 13 U.S. cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 14 U.S. cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 15 Canada cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 16 Canada cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 17 Canada cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 18 Canada cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 19 Canada cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 20 Europe cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 21 Europe cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 22 Europe cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 23 Europe cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 24 Europe cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 25 Germany cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 26 Germany cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 27 Germany cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 28 Germany cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 29 Germany cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 30 U.K. cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 31 U.K. cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 32 U.K. cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 33 U.K. cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 34 U.K. cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 35 France cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 36 France cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 37 France cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 38 France cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 39 France cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 40 Spain cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 41 Spain cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 42 Spain cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 43 Spain cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 44 Spain cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 45 Italy cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 46 Italy cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 47 Italy cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 48 Italy cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 49 Italy cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 50 Asia Pacific cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 51 Asia Pacific cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 52Asia Pacific cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 53 Asia Pacific cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 54 Asia Pacific cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 55 Japan cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 56 Japan cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 57 Japan cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 58 Japan cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 59 Japan cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 60 China cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 61 China cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 62 China cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 63 China cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 64 China cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 65 India cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 66 India cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 67 India cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 68 India cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 69 India cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 70 South Korea cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 71 South Korea cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 72 South Korea cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 73 South Korea cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 74 South Korea cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 75 Thailand cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 76 Thailand cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 77 Thailand cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 78 Thailand cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 79 Thailand cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 80 Latin America cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 81 Latin America cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 82 Latin America cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 83 Latin America cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 84 Latin America cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 85 Brazil cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 86 Brazil cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 87 Brazil cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 88 Brazil cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 89 Brazil cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 90 Mexico cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 91 Mexico cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 92 Mexico cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 93 Mexico cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 94 Mexico cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 95 Argentina cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 96 Argentina cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 97 Argentina cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 98 Argentina cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 99 Argentina cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 100 MEA cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 101 MEA cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 102 MEA cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 103 MEA cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 104 MEA cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 105 South Africa cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 106 South Africa cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 107 South Africa cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 108 South Africa cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 109 South Africa cancer biopsy market, by application, 2018 - 2027 (USD Million)
Table 110 Saudi Arabia cancer biopsy market, by product, 2018 - 2027 (USD Million)
Table 111 Saudi Arabia cancer biopsy market, by type, 2018 - 2027 (USD Million)
Table 112 Saudi Arabia cancer tissue biopsy market, by type, 2018 - 2027 (USD Million)
Table 113 Saudi Arabia cancer needle biopsy market, by type 2018 - 2027 (USD Million)
Table 114 Saudi Arabia cancer biopsy market, by application, 2018 - 2027 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 End-use landscape: Cancer biopsy product penetration
Fig. 8 Cancer biopsy: Market origin/ parent market assessment
Fig. 9 Market competition analysis: Early diagnosis industry sector
Fig. 10 Market formulation & validation
Fig. 11 Cancer biopsy market snapshot
Fig. 12 Cancer biopsy market segmentation
Fig. 13 Biopsy workflow
Fig. 14 Biopsy types
Fig. 15 Top 10 companies in the liquid biopsy business
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Cancer Biopsy market driver impact
Fig. 18 External factors driving the demand for cancer biopsy
Fig. 19 Cancer Biopsy market restraint impact
Fig. 20 Porter’s Five Forces Analysis
Fig. 21 Factors impacting market entry strategies
Fig. 22 Ansoff Matrix
Fig. 23 Competition Categorization
Fig. 24 Cancer biopsy market: Products outlook and key takeaways
Fig. 25 Cancer biopsy market: Product movement analysis
Fig. 26 Cancer biopsy instruments market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 27 Cancer Biopsy Kits: Cardinal Health
Fig. 28 Cancer biopsy kits and consumables market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 29 Cancer biopsy services market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 30 Cancer biopsy market: Type outlook and key takeaways
Fig. 31 Cancer biopsy market: Type movement analysis
Fig. 32Tissue Biopsy Vs Liquid Biopsy: Comparative Analysis
Fig. 33 Cancer tissue biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 34 Cancer needle biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 35 Estimated increment in thyroid cancer cases/thyroid cancer FNAB diagnosis in Korea:2005-2013
Fig. 36 Fine needle aspiration (FNA) market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 37 Core needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 38 Surgical biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 39 Liquid biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 40 Other biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 41 Cancer biopsy market: Application outlook and key takeaways
Fig. 42 Cancer Biopsy market: Application Movement Analysis
Fig. 43 New female breast in situ cancer cases by age estimated in the U.S.: 2017
Fig. 44 New female breast invasive cancer cases by age estimated in the U.S.: 2017
Fig. 45 New female breast cancer deaths by age estimated in the U.S.: 2017
Fig. 46 Breast cancer biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 47 Colorectal cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 48 Cervical cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 49 Lung cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 50 Prostate cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 51 Skin cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 52 Blood cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 53 Kidney cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 54 Liver cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 55 Pancreatic cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 56 Ovarian cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 57 Other cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 58 Cancer biopsy market: Regional outlook and key takeaways
Fig. 59 Cancer biopsy market: Regional movement analysis
Fig. 60 North America cancer biopsy market overview
Fig. 61 North America cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 62 U.S. cancer biopsy market overview
Fig. 63 U.S. cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 64 Canada cancer biopsy market overview
Fig. 65 Canada cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 66 Europe cancer biopsy market overview
Fig. 67 Europe cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 68 Germany cancer biopsy market overview
Fig. 69 Germany cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 70 U.K. cancer biopsy market overview
Fig. 71 U.K. cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 72 France cancer biopsy market overview
Fig. 73 France cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 74 Spain cancer biopsy market overview
Fig. 75 Spain cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 76 Italy cancer biopsy market overview
Fig. 77 Italy cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 78 Asia Pacific cancer biopsy market overview
Fig. 79 Asia Pacific cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 80 Japan cancer biopsy market overview
Fig. 81 Japan cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 82 China cancer biopsy market overview
Fig. 83 China cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 84 India cancer biopsy market overview
Fig. 85 India cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 86 Thailand cancer biopsy market overview
Fig. 87 Thailand cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 88 South Korea cancer biopsy market overview
Fig. 89 South Korea cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 90 Latin America cancer biopsy market overview
Fig. 91 Latin America cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 92 Brazil cancer biopsy market overview
Fig. 93 Brazil cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 94 Mexico cancer biopsy market overview
Fig. 95 Mexico cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 96 Argentina cancer biopsy market overview
Fig. 97 Argentina cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 98 Middle East & Africa cancer biopsy market overview
Fig. 99 MEA cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 100 South Africa cancer biopsy market overview
Fig. 101 South Africa cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 102 Saudi Arabia cancer biopsy market overview
Fig. 103 Saudi Arabia cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 End-use landscape: Cancer biopsy product penetration
Fig. 8 Cancer biopsy: Market origin/ parent market assessment
Fig. 9 Market competition analysis: Early diagnosis industry sector
Fig. 10 Market formulation & validation
Fig. 11 Cancer biopsy market snapshot
Fig. 12 Cancer biopsy market segmentation
Fig. 13 Biopsy workflow
Fig. 14 Biopsy types
Fig. 15 Top 10 companies in the liquid biopsy business
Fig. 16 Penetration and growth prospect mapping
Fig. 17 Cancer Biopsy market driver impact
Fig. 18 External factors driving the demand for cancer biopsy
Fig. 19 Cancer Biopsy market restraint impact
Fig. 20 Porter’s Five Forces Analysis
Fig. 21 Factors impacting market entry strategies
Fig. 22 Ansoff Matrix
Fig. 23 Competition Categorization
Fig. 24 Cancer biopsy market: Products outlook and key takeaways
Fig. 25 Cancer biopsy market: Product movement analysis
Fig. 26 Cancer biopsy instruments market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 27 Cancer Biopsy Kits: Cardinal Health
Fig. 28 Cancer biopsy kits and consumables market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 29 Cancer biopsy services market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 30 Cancer biopsy market: Type outlook and key takeaways
Fig. 31 Cancer biopsy market: Type movement analysis
Fig. 32Tissue Biopsy Vs Liquid Biopsy: Comparative Analysis
Fig. 33 Cancer tissue biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 34 Cancer needle biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 35 Estimated increment in thyroid cancer cases/thyroid cancer FNAB diagnosis in Korea:2005-2013
Fig. 36 Fine needle aspiration (FNA) market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 37 Core needle biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 38 Surgical biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 39 Liquid biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 40 Other biopsies market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 41 Cancer biopsy market: Application outlook and key takeaways
Fig. 42 Cancer Biopsy market: Application Movement Analysis
Fig. 43 New female breast in situ cancer cases by age estimated in the U.S.: 2017
Fig. 44 New female breast invasive cancer cases by age estimated in the U.S.: 2017
Fig. 45 New female breast cancer deaths by age estimated in the U.S.: 2017
Fig. 46 Breast cancer biopsy market estimates and forecasts, 2018 - 2027 (USD Million)
Fig. 47 Colorectal cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 48 Cervical cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 49 Lung cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 50 Prostate cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 51 Skin cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 52 Blood cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 53 Kidney cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 54 Liver cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 55 Pancreatic cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 56 Ovarian cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 57 Other cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 58 Cancer biopsy market: Regional outlook and key takeaways
Fig. 59 Cancer biopsy market: Regional movement analysis
Fig. 60 North America cancer biopsy market overview
Fig. 61 North America cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 62 U.S. cancer biopsy market overview
Fig. 63 U.S. cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 64 Canada cancer biopsy market overview
Fig. 65 Canada cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 66 Europe cancer biopsy market overview
Fig. 67 Europe cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 68 Germany cancer biopsy market overview
Fig. 69 Germany cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 70 U.K. cancer biopsy market overview
Fig. 71 U.K. cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 72 France cancer biopsy market overview
Fig. 73 France cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 74 Spain cancer biopsy market overview
Fig. 75 Spain cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 76 Italy cancer biopsy market overview
Fig. 77 Italy cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 78 Asia Pacific cancer biopsy market overview
Fig. 79 Asia Pacific cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 80 Japan cancer biopsy market overview
Fig. 81 Japan cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 82 China cancer biopsy market overview
Fig. 83 China cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 84 India cancer biopsy market overview
Fig. 85 India cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 86 Thailand cancer biopsy market overview
Fig. 87 Thailand cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 88 South Korea cancer biopsy market overview
Fig. 89 South Korea cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 90 Latin America cancer biopsy market overview
Fig. 91 Latin America cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 92 Brazil cancer biopsy market overview
Fig. 93 Brazil cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 94 Mexico cancer biopsy market overview
Fig. 95 Mexico cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 96 Argentina cancer biopsy market overview
Fig. 97 Argentina cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 98 Middle East & Africa cancer biopsy market overview
Fig. 99 MEA cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 100 South Africa cancer biopsy market overview
Fig. 101 South Africa cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
Fig. 102 Saudi Arabia cancer biopsy market overview
Fig. 103 Saudi Arabia cancer biopsy market estimates and forecast, 2018 - 2027 (USD Million)
